Omniab (NASDAQ: OABI) net income
Omniab reported a net loss of $64.8m for fiscal 2025; in fiscal 2024 it reported a net loss of $62.0m. Earnings per share were −$0.57.
Omniab's best year of the last 5 was fiscal 2022. It reported a loss in 5 of those 5 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$64.8m | — | −347.0% | −$0.57 |
| 2024 | −$62.0m | — | −235.1% | −$0.61 |
| 2023 | −$50.6m | — | −148.2% | −$0.51 |
| 2022 | −$22.3m | — | −37.8% | −$0.26 |
| 2021 | −$27.0m | — | −77.8% | −$0.33 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Omniab net income compared with its sector
By net income for its latest fiscal year, Omniab ranks 283rd of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Omniab, −347.0%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 281st | Lineage Cell Therapeutics | −$63.5m | −436.5% |
| 282nd | Simulations Plus | −$64.7m | −81.7% |
| 283rd | Omniab | −$64.8m | −347.0% |
| 284th | Aclaris Therapeutics | −$64.9m | −829.6% |
| 285th | Arcturus Therapeutics | −$65.8m | −80.2% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Omniab
- How much did Omniab earn in fiscal 2025?
- Omniab reported a net loss of $64.8m for fiscal 2025. In fiscal 2024 it reported a net loss of $62.0m.
- What are the earnings per share of Omniab?
- They were −$0.57 in fiscal 2025, compared with −$0.61 in fiscal 2024.
- Where does Omniab rank in its sector by net income?
- It ranks 283rd of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Omniab come from?
- From the annual report (Form 10-K) that Omniab files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Omniab files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021. More on Omniab: the Omniab page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.